Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33.2M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
10.9M
-
Shares change
-
+10.9M
-
Total reported value, excl. options
-
$259M
-
Value change
-
+$259M
-
Number of buys
-
44
-
Price
-
$23.79
Significant Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q2 2021
44 filings reported holding NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share as of Q2 2021.
NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.9M shares
of 33.2M outstanding shares and own 32.81% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4.01M shares), Soleus Capital Management, L.P. (1.38M shares), FMR LLC (1.06M shares), Bellevue Group AG (508K shares), PICTET ASSET MANAGEMENT LTD (486K shares), Sectoral Asset Management Inc (472K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (453K shares), AMERICAN CENTURY COMPANIES INC (403K shares), BlackRock Inc. (334K shares), and VANGUARD GROUP INC (292K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.